Differential Effects of Oxytocin Receptor Antagonists, Atosiban and Nolasiban, on Oxytocin Receptor–Mediated Signaling in Human Amnion and Myometrium

April 1, 2017

Nolasiban

Differential Effects of Oxytocin Receptor Antagonists, Atosiban and Nolasiban, on Oxytocin Receptor–Mediated Signaling in Human Amnion and Myometrium Sung Hye…

Read more

THE ‘ART’ OF WOMEN’S HEALTH – Add back or not add back? Obseva: Both options good as UF, endo trials continue

March 30, 2017

Linzagolix

THE ‘ART’ OF WOMEN’S HEALTH – Add back or not add back? Obseva: Both options good as UF, endo trials…

Read more

Both OTR Antagonists, Atosiban and Nolasiban, Inhibits PGE2/PGF2α-Induced Contractions of Human Pregnant Myometrium In Vitro.

March 18, 2017

Nolasiban

Sung Hye Kim, Hauwa Ahmed, Lucia Riaposova, Oliver Pohl, Andre Chollet, Aylin Hanyaloglu, Phillip R Bennett, Vasso Terzidou SRI Conference,…

Read more

The OTR Antagonist, OBE001, Inhibits Both Spontaneous and OT-Induced Contractions of Human Pregnant Myometrium In Vitro.

March 16, 2016

Nolasiban

Shankari Arulkumaran, Sung Hye Kim, Oliver Pohl, Andre Chollet, Phillip R. Bennett and Vasso Terzidou SRI Conference, 16-19 March 2016, Montreal, CANADA

Read more

The OTR Antagonist, OBE001, Inhibits OT-Driven Proinflammatory Effects in Both Human Myometrium and Amnion.

Nolasiban

Sung Hye Kim, Oliver Pohl, Andre Chollet, Adam Fairhurst, Phillip R Bennett, Vasso Terzidou SRI Conference, 16-19 March 2016, Montreal, CANADA

Read more

The OTR Antagonist, OBE001, Suppresses the Effects of OT on miRNA Expression in Human Myometrium.

Nolasiban

Sung Hye Kim, Stacey Robinson, Joanna Cook, Oliver Pohl, Andre Chollet, Phillip R Bennett, Vasso Terzidou. SRI Conference, 16-19 March 2016, Montreal, CANADA

Read more